A highly stable double-layer essence composition, cosmetic, preparation method and application thereof.

By combining emulsifiers and thickeners in a specific ratio, the stability of fibronectin in cosmetics has been solved, achieving long-term stability of the double-layer essence and preservation of the bioactivity of fibronectin, thus promoting skin cell repair.

CN123058960APending Publication Date: 2026-11-10GUANGDONG KANG RONG IND CO LTD +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202611547678.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-08
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing technologies cannot effectively improve the stability of fibronectin, which leads to the easy separation of the double-layer essence in the milk foam during storage and the demulsification of the emulsion. Furthermore, the bioactivity of fibronectin is easily affected by environmental factors, thus affecting its application effect in cosmetics.

Method used

A highly stable bilayer essence composition is formed by using polyglycerol-3 stearate and polysorbate 20 in a specific ratio as emulsifiers, xanthan gum and sodium chloride as thickeners, and fibronectin. By controlling the ratio and amount of emulsifiers and thickeners, the bioactivity and stability of fibronectin are ensured.

Benefits of technology

It significantly reduced the layering index and viscosity change rate of the double-layer essence, enhanced the bioactivity of fibronectin and the skin cell repair capacity, promoted the healing of skin wounds, and maintained the long-term stability and biocompatibility of cosmetics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

This invention, entitled "A Highly Stable Two-Layer Essence Composition, Cosmetic, Preparation Method thereof, and Application," belongs to the field of cosmetic technology. The technical problem to be solved is to improve the stability and repair capabilities of fibronectin and the composition. The key technical points are: a highly stable two-layer essence composition comprising: fibronectin, an emulsifier, and a thickener; the emulsifier is polyglycerol-3 stearate or a mixture of polyglycerol-3 stearate and polysorbate 20 at a mass ratio of 2:(0.8-1); the thickener is xanthan gum and sodium chloride at a mass ratio of 2:(0.8-1).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention provides a highly stable double-layer essence composition, cosmetic, preparation method and application thereof, belonging to the field of cosmetic technology. Background Technology

[0002] Milk foam double-layer essences typically consist of two immiscible phases, creating an aesthetically pleasing layered appearance while delivering multiple active ingredients through different layers. However, the inherent thermodynamic instability of such systems presents significant formulation challenges, particularly regarding phase separation, emulsion demulsification, and ingredient degradation during storage.

[0003] Fibronectin (FN) is a high-molecular-weight glycoprotein (440-500 kDa) widely distributed in the extracellular matrix and body fluids. It plays a fundamental role in various biological processes such as cell adhesion, migration, proliferation, and tissue repair. In skincare applications, FN has shown remarkable efficacy in promoting wound healing, enhancing skin barrier function, and supporting dermal regeneration.

[0004] However, its sensitivity to environmental factors such as pH, temperature, ionic strength, and mechanical stress limits its application conditions. The tertiary structure of fluorescein (FN) is easily disrupted, leading to loss of biological activity. Therefore, when integrating FN into complex delivery systems such as cosmetics, it is essential to ensure its stability in the formulation while maintaining its biological functions.

[0005] Relevant patent documents retrieved: The document, published in China (CN108379135A) on August 10, 2018, discloses a composition of Ganoderma lucidum extract, its extraction process, and its application. The emulsifier includes polyglycerol-3 diisostearate, etc.; the stabilizer includes sodium chloride, etc.; and the gum raw material includes xanthan gum, etc. The mass ratio of the emulsifier, thickener, and stabilizer in this patent is (1-5):(0.05-0.5):(0.1-2).

[0006] The document, published in China (CN113768823A) on December 10, 2021, discloses a highly effective soothing, repairing, and antioxidant serum containing fibronectin extract. The serum comprises the following components: 5-10 parts water, 5-10 parts glycerin, 1-3 parts butylene glycol, 3 parts glyceryl polyether-261, 1-3 parts hydroxyethyl urea, 1-3 parts polydimethylsiloxane, 5-10 parts fibronectin extract, 3 parts polyethylene glycol-81, 1-3 parts tocopherol, and hyaluronic acid. Sodium acetone 1-3 parts, α-arbutin 1-3 parts, glyceryl glucoside 1-3 parts, panthenol 1-3 parts, soybean fermentation product filtrate 1-3 parts, 1,2-pentanediol 1-3 parts, acetyl hexapeptide-8 1-3 parts, ethylhexylglycerin 1-3 parts, ammonium acryloyldimethyl taurate 1-3 parts, polyacrylate crosspolymer-6 1-3 parts, hydrogenated lecithin 1-3 parts, cetearyl alcohol 1-3 parts, cetearyl glucoside 1-3 parts, p-hydroxyacetophenone 1-3 parts, 1,2-hexanediol 1-3 parts.

[0007] Relevant non-patent literature retrieved: The journal or book title is *Experimental Fluid Mechanics*, and the document title is "Experimental Study on Drag Reduction and Shear Resistance Properties of Xanthan Gum Salt Solution," Volume 32, Issue 5, Publication Date: October 2018. This document discloses an experimental study on the drag reduction and shear resistance properties of a 1:1 xanthan gum salt solution with added sodium chloride in a smooth circular tube with a diameter of 20 mm. The drag reduction rate of xanthan gum salt solutions with different mass fractions was obtained as a function of the Reynolds number and running time, and compared with the drag reduction and shear resistance properties of xanthan gum aqueous solution. The results show that compared to xanthan gum aqueous solution, the drag reduction rate of the xanthan gum salt solution with added NaCl tends to stabilize more rapidly with increasing Reynolds number. However, its drag reduction rate is lower than that of xanthan gum aqueous solution at lower Reynolds numbers, and significantly higher at higher Reynolds numbers. The xanthan gum salt solution exhibits strong temperature resistance. Under continuous cyclic shearing, xanthan gum salt solutions with different mass fractions all exhibit good shear resistance properties.

[0008] The prior art represented by the aforementioned documents has at least the following unresolved technical problems or defects: Patents CN108379135A and CN113768823A did not conduct research on improving the stability of fibronectin, and therefore cannot further enhance its stability. While the study "Experimental Study on Drag Reduction and Shear Resistance Properties of Xanthan Gum Salt Solution" used a combination of NaCl and xanthan gum, this is not within the cosmetics field, and the 1:1 ratio of NaCl to xanthan gum cannot further improve the stability of fibronectin. Summary of the Invention

[0009] The purpose of this invention is to provide: A highly stable double-layer essence composition, cosmetic, preparation method and application thereof, and related technologies to solve technical problems such as improving fibronectin and the stability and repair ability of the composition, or combinations thereof.

[0010] Terminology Explanation: Unless otherwise defined, all technical terms used herein have the same meanings as commonly understood by one of ordinary skill in the art to which the subject matter pertains. Unless otherwise stated, all patents, patent inventions, and publications cited throughout this document are incorporated herein by reference in their entirety. Where multiple definitions exist for terms, the definitions provided in this chapter shall prevail.

[0011] It should be understood that the above brief description and the following detailed description are exemplary and for illustrative purposes only, and do not limit the subject matter of the invention in any way. In this invention, the singular is used in conjunction with the plural unless otherwise specifically stated. It should also be noted that, unless otherwise stated, the use of “or” or “or” means “and / or”. Furthermore, the use of the term “comprising” and other forms such as “including,” “containing,” and “contains” are not limiting.

[0012] Definitions of standard chemical terms can be found in the reference "Cosmetic Safety Technical Specifications".

[0013] Unless otherwise stated, conventional methods within the scope of the art, such as stability tests, shall be used.

[0014] Unless specifically defined herein, the use of all commercially available products herein employs standard techniques. For example, it may be carried out using the manufacturer's instructions for use with the kit, or in accordance with methods known in the art or the description of this invention. The techniques and methods described herein can generally be implemented according to conventional methods well known in the art, based on the descriptions in the various summary and more specific documents cited and discussed in this specification.

[0015] The terms “optional / arbitrary” or “optionally / arbitrarily” mean that the event or situation described below may or may not occur, including both the occurrence and non-occurrence of the event or situation.

[0016] In this invention, PGS refers to polyglycerol-3 stearate.

[0017] In a first aspect, the present invention provides: a highly stable bilayer essence composition comprising: fibronectin, an emulsifier, and a thickener; The emulsifier is: polyglycerol-3 stearate or polyglycerol-3 stearate and polysorbate 20 in a mass ratio of 2:(0.8-1); The thickener is xanthan gum and sodium chloride in a mass ratio of 2:(0.8-1).

[0018] In some embodiments, the emulsifier accounts for 3-4% of the mass of the double-layer essence.

[0019] In some embodiments, the thickener accounts for 0.3-0.8% of the mass of the double-layer essence.

[0020] In some embodiments, the mass ratio of the fibronectin, emulsifier and thickener is (1.5-2.5):(3-4):(0.3-0.8).

[0021] In some embodiments, the emulsifier is a range of polyglycerol-3 stearate and polysorbate 20, or any combination thereof, in a mass ratio of 2:1, 2:0.9, or 2:0.8.

[0022] In some embodiments, the thickener is xanthan gum and sodium chloride in a mass ratio of 2:1, 2:0.9, 2:0.8, or any combination thereof.

[0023] In some embodiments, the emulsifier comprises 3%, 3.5%, 4% of the mass of the double-layer essence, or any combination thereof.

[0024] In some embodiments, the thickener comprises 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8% of the weight of the double-layer essence, or any combination thereof.

[0025] In some embodiments, the mass ratio of the fibronectin, emulsifier, and thickener is 1.5:4:0.8, 2:4:0.8, 2.5:4:0.8, 1.5:3:0.8, 1.5:3:0.3, 2:3:0.3, 2:3:0.8, or any combination thereof.

[0026] In some implementations, the dual-layer essence further includes: oils, heat-sensitive ingredients, moisturizers, and chelating agents.

[0027] Preferably, the oil comprises at least one of mineral oil, meadowfoam seed oil, squalane, and isohexadecane.

[0028] Preferably, the heat-sensitive component includes at least one of: gentian root extract, lactobacillus / soy milk fermentation product filtrate, p-hydroxyacetophenone, and 1,2-hexanediol.

[0029] Preferably, the moisturizer includes at least one of glycerin, butylene glycol, allantoin, and betaine.

[0030] Preferably, the chelating agent comprises: disodium EDTA.

[0031] Secondly, the present invention provides a method for preparing the above-mentioned composition, comprising the following steps: (1) Heat the oil and emulsifier to 75-80℃ to obtain the oil phase, and add water to the thickener and heat to 80-85℃ to obtain the aqueous phase; (2) Under homogeneous conditions, the oil phase is added to the aqueous phase, cooled to 40-45℃, and then fibronectin is added, stirred and cooled.

[0032] In some implementations, the homogenization in step (2) is 2000-4000 rpm.

[0033] Thirdly, the present invention provides a cosmetic product comprising the above-described composition.

[0034] Fourthly, the present invention provides the use of the above composition in the preparation of cosmetics.

[0035] The present invention has at least the following beneficial effects: 1. Compared with existing technologies, the present invention has better technical effects in terms of the stability of the double-layer essence layering, the stability of system viscosity, the preservation of fibronectin bioactivity, and the ability to repair and promote skin cell regeneration.

[0036] According to experimental tests, the present invention reduces the stratification index (DI) from 6.5% in the prior art to below 3.8%.

[0037] According to experimental tests, the present invention reduces the viscosity change rate (VCR) from 15.2% in the prior art to below 9.8%.

[0038] According to experimental tests, this invention increases cell viability from 100.0% in the blank control group without fibronectin to 115.3%.

[0039] According to experimental tests, this invention increases the closure rate of cell scratch wounds by 48 hours from 47.7% in the blank control group to 72.5%.

[0040] Furthermore, based on the present invention: Based on the comparison of Example 1 and Comparative Examples 1-3, this invention utilizes polyglycerol-3 stearate as the main emulsifier, combined with a specific mass ratio of xanthan gum and sodium chloride as a thickener, and achieves new technical effects: it significantly reduces the degree of stratification and viscosity fluctuations during the high-temperature and cold-heat cycling storage of the double-layer essence, maintaining the appearance of the double-layer milk foam for a long time; it also avoids the damage to the spatial structure of fibronectin caused by ions and the emulsification system, fully preserving the biological activity of fibronectin in promoting cell proliferation and accelerating skin wound healing. The formula is non-cytotoxic and has excellent biocompatibility. The combined technical effect is superior to the sum of the effects of individually adjusting the type / amount of emulsifier or individually adjusting the ratio of xanthan gum and sodium chloride. Detailed Implementation

[0041] The following non-limiting embodiments are intended to enable those skilled in the art to gain a more comprehensive understanding of the present invention, but do not limit the invention in any way. The following content is merely an exemplary description of the scope of protection claimed by the present invention, and those skilled in the art can make various changes and modifications to the present invention based on the disclosed content, and such changes should also fall within the scope of protection claimed by the present invention.

[0042] The present invention will be further described below by way of specific embodiments. Unless otherwise specified, all instruments, devices, equipment, reagents, products, etc., used in the embodiments of the present invention are obtained through conventional commercial means.

[0043] Sources of some commercially available reagents: Gentian root extract: Zhejiang Zhongke Planting Biotechnology Co., Ltd.

[0044] Lactobacillus / soy milk fermentation product filtrate: AXIALYS INNOVATIONS, model: OPTIMEALTH® 10W.

[0045] Fibronectin: Recombinant human, purity >95%, purchased from Guangdong Kangrong Industrial Co., Ltd. (Guangzhou, China).

[0046] DMEM medium, fetal bovine serum, phosphate buffer, and trypsin-EDTA were purchased from Gibco (USA).

[0047] The CCK-8 kit was purchased from Dojindo (Japan).

[0048] The raw material composition of Examples 1-2 and Comparative Examples 1-3 is shown in Table 1.

[0049] Table 1. Raw material composition of Examples 1-2 and Comparative Examples 1-3 (unit: mass percentage, %)

[0050] The preparation methods of Examples 1-2 and Comparative Examples 1-3 are as follows: (1) Mineral oil, meadowfoam seed oil, squalane, isohexadecane and emulsifier are heated to 75°C to obtain the oil phase, and glycerol, butanediol, allantoin, disodium EDTA, betaine and thickener are added to water and heated to 80°C to obtain the aqueous phase; (2) Under homogenization (3000 rpm) conditions, the oil phase is added to the aqueous phase, cooled to 40-45℃, and then fibronectin, gentian root extract, lactobacillus / soy milk fermentation product filtrate, p-hydroxyacetophenone and 1,2-hexanediol are added. Stir and cool to obtain the final product.

[0051] Stability analysis of test case 1 Heat resistance test The samples were stored at 45±1℃ for 4 weeks. Visual observation and measurements were performed at weeks 0, 1, 2 and 4.

[0052] Evaluation indicators The formula for calculating the stratification index is: DI = (separation layer height / total height) × 100%.

[0053] The formula for calculating the viscosity change rate is: VCR = |(V1- V0) / V0|×100%.

[0054] Where V0 is the initial viscosity and V1 is the viscosity after storage.

[0055] Experimental results The experimental results are shown in Table 2.

[0056] Table 2

[0057] Cell safety assessment in test case 2 Samples: Examples 1-2 and Comparative Examples 1-3.

[0058] (1) Experimental methods ① Cell viability experiment HaCaT cells were cultured in DMEM medium supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C in a humidified incubator with 5% CO2. To assess viability, cells were sputtered at a rate of 5 × 10⁶ cells / year. 3 Cells were seeded at a density per well in 96-well plates and cultured for 24 hours.

[0059] The sample was then diluted 100-fold in culture medium, and then 100 μL was used to treat cells (5 × 10⁶ cells / year). 3 Cells / well) for 24 hours. Cell viability was determined using a CCK-8 assay kit according to the manufacturer's instructions. Absorbance was measured at 450 nm using a microplate reader.

[0060] Control formulation preparation (NC group) A control formulation without fibronectin was prepared, with the same basic composition as the formulation in Example 1, to distinguish the effects of the optimized emulsification-thickening system on FN bioactivity.

[0061] ② Cell scratch test HaCaT cells were seeded in 6-well plates and cultured until confluence. A straight line was created in the cell monolayer using a sterile 200 μL pipette tip. The cells were washed with PBS, and then treated with 2 mL of a sample diluted 100-fold with culture medium (6 × 10⁶ cells / well). 5(cells / well) for 24 hours. Images were taken using an inverted microscope at 0, 24, and 48 hours. The wound closure rate and relative migration rate were calculated as follows: Relative mobility (%) = (W0 - W) t ) / W0 × 100%, where W0 is the initial scratch width, W t The width of the scratch at time t.

[0062] Where A0 is the initial wound area at 0h, and A1 is the wound area at 24h / 48h.

[0063] Statistical analysis All experiments were performed in triplicate. Data are presented as mean ± standard deviation. One-way ANOVA was used, followed by Tukey's post-hoc test to determine statistical significance. A p-value < 0.05 was considered statistically significant.

[0064] (2) Experimental results ① Cell viability was determined using the CCK-8 assay to assess the biocompatibility of different formulations. The experimental results are shown in Table 3.

[0065] Compared with the NC group, all groups maintained cell viability above 95% and no cytotoxicity was observed.

[0066] The Example 1 group showed significantly enhanced cell viability (115.3±4.2%, p<0.01), indicating that the optimized emulsification-thickening system can not only maintain FN stability, but also enhance its bioavailability or synergistically promote cell proliferation.

[0067] Table 3

[0068] Note: The significance in Table 3 is compared with the NC group. p<0.01 vs NC group.

[0069] ② A scratch assay was used to assess wound healing ability and to examine the retention of FN bioactivity in different formulations. As shown in Table 4, compared with the NC group, all test groups showed enhanced cell migration ability, confirming the retention of FN bioactivity in the formulations.

[0070] At 24 hours, Example 1 showed the highest wound closure rate (52.8 ± 2.9%) and the highest relative migration rate at both time points, increasing by 1.55 times compared to the control group at 48 hours. This confirms the superior bioactivity of the optimized formulation.

[0071] Relative mobility rates were calculated to standardize the data and facilitate inter-group comparisons (Table 5).

[0072] Table 4. Scratch Test Results - Closure Rate (%) (n=3)

[0073] Note: The significance in Table 4 is compared with the NC group. p<0.05, p<0.01.

[0074] Table 5. Relative migration rates at different time points (n=3)

[0075] Verification of technical effectiveness and / or analysis of technical problem solving This invention addresses the shortcomings of existing double-layer milk foam, such as poor thermal stability of the essence, easy separation and emulsification during storage, and insufficient cell vitality and skin repair and regeneration effects. By limiting the types, ratios and amounts of specific emulsifiers, and combining them with a xanthan gum-sodium chloride precisely formulated thickening system, the stability and wound closure rate of the product are improved.

[0076] The results of the heat resistance storage test for 4 weeks showed that the layering index (DI) of Example 1 of the present invention was 3.8% and the viscosity change rate (VCR) was only 9.8%, which effectively suppressed the problems of system layering and drastic viscosity fluctuations under long-term high temperature storage, and maintained the layered appearance of the double-layer essence for a long time.

[0077] Simultaneously, cell experiments showed that this invention could increase HaCaT cell viability to 115.3%, which was significantly different from the NC group. The closure rate of cell-induced scratch wounds reached 52.8% at 24 hours and 72.5% at 48 hours, promoting skin cell proliferation and wound repair.

[0078] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, and is not intended to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions made by those skilled in the art to the technical solution of the present invention do not depart from the essence and scope of the technical solution of the present invention.

Claims

1. A highly stable double-layer essence composition, characterized in that, include: Fibronectin, emulsifiers, and thickeners; The emulsifier is: polyglycerol-3 stearate or polyglycerol-3 stearate and polysorbate 20 in a mass ratio of 2:(0.8-1); The thickener is xanthan gum and sodium chloride in a mass ratio of 2:(0.8-1).

2. The composition according to claim 1, characterized in that, The emulsifier accounts for 3-4% of the mass of the double-layer essence.

3. The composition according to claim 1, characterized in that, The thickener accounts for 0.3-0.8% of the mass of the double-layer essence.

4. The composition according to claim 1, characterized in that, The mass ratio of fibronectin, emulsifier and thickener is (1.5-2.5):(3-4):(0.3-0.8).

5. The composition according to claim 1, characterized in that, The dual-layer essence also includes: oils, heat-sensitive ingredients, moisturizers, and chelating agents.

6. The composition according to claim 5, characterized in that, The oils include at least one of mineral oil, meadowfoam seed oil, squalane, and isohexadecane.

7. The composition according to claim 5, characterized in that, The heat-sensitive ingredients include at least one of the following: gentian root extract, lactobacillus / soy milk fermentation product filtrate, p-hydroxyacetophenone, and 1,2-hexanediol; the moisturizers include at least one of the following: glycerin, butylene glycol, allantoin, and betaine.

8. A method for preparing the composition according to any one of claims 1-7, characterized in that, Includes the following steps: (1) Heat the oil and emulsifier to 75-80℃ to obtain the oil phase, and add water to the thickener and heat to 80-85℃ to obtain the aqueous phase; (2) Under homogeneous conditions, the oil phase is added to the aqueous phase, cooled to 40-45℃, and then fibronectin is added, stirred and cooled.

9. A cosmetic product, characterized in that, Includes the composition according to any one of claims 1-7.

10. Use of the composition according to any one of claims 1-7 in the preparation of cosmetics.

Citation Information

Patent Citations

  • Ganoderma sinense extract composition as well as extraction technology and application thereof

    CN108379135A

  • Efficient soothing, repairing and anti-oxidation essence containing fibronectin extract component

    CN113768823A